Highlights of Ophthalmology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  52 (2024)
Volume  51 (2023)
Volume  50 (2022)
Volume  49 (2021)
Volume  48 (2020)
Volume  47 (2019)
Volume  46 (2018)
Volume  45 (2017)
Volume  44 (2016)
Volume  43 (2015)
Volume  42 (2014)
Volume  41 (2013)
Volume  40 (2012)
Volume  39 (2011)
Volume  38 (2009)
Related articles

VOLUME 50 , ISSUE 3ESP ( June, 2022 ) > List of Articles

Actualización en Métodos Diagnósticos para el Estudio del Ojo Seco

Dr. Ricardo Navarro-Saucedo, Dr. Manuel Alejandro Garza León, Dr. Francisco Beltrán Díaz de la Vega

Keywords : Artículo de revisión, ojo seco, película lagrimal, métodos diagnósticos

Citation Information : Navarro-Saucedo DR, León DM, de la Vega DF. Actualización en Métodos Diagnósticos para el Estudio del Ojo Seco. 2022; 50 (3ESP):15-27.

DOI: 10.5005/hoe-10101-50303

Published Online: 08-06-2022

Copyright Statement:  Copyright © 2022; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Objetivo: Realizar una actualización de la evidencia acerca de los métodos diagnósticos en la enfermedad de ojo seco. Antecedentes: La enfermedad de ojo seco es un padecimiento prevalente, para el cual existen múltiples métodos diagnósticos para su abordaje. A pesar de la publicación del Taller de Ojo Seco Internacional II en 2017 y más recientemente el de la Sociedad Asiática de Ojo Seco, el diagnóstico continúa siendo muy variable y subjetivo entre los profesionales, por lo que es importante tratar de estandarizar los métodos, así como utilizar aquellos que son más objetivos. Revisión de Resultados: Reconociendo que el ojo seco es una enfermedad eminentemente sintomática, el uso de cuestionarios validados es de suma importancia, por lo que en esta revisión se describen los cuestionarios recientemente validados para nuestro medio. Además, teniendo en cuenta que el orden de los estudios puede modificar sus resultados, se discute el orden y la forma correcta para realizar los estudios sugeridos por los consensos antes mencionados. Finalmente, se mencionan algunos de los estudios actualmente en investigación que permiten reconocer la fisiopatología de la enfermedad, así como la forma de evaluar el impacto del ojo seco en la visión. Conclusión: Además del abordaje clásico, nuevas técnicas diagnósticas nos permiten mejorar nuestro entendimiento sobre el ojo seco. Los nuevos aspectos mencionados son útiles en la práctica diaria, y para elegir variables y pruebas diagnósticas a ser usadas en estudios de investigación.

PDF Share
  1. Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, et al. TFOS DEWS II Definition and classification report. Ocul Surf. 2017 Jul;15(3):276-283.
  2. Nelson JD, Craig JP, Akpek EK, Azar DT, Belmonte C, Bron AJ, et al. TFOS DEWS II Introduction. Ocul Surf. 2017 Jul;15(3):269-275.
  3. Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K, et al. TFOS DEWS II Diagnostic methodology report. Ocul Surf. 2017 Jul;15(3):539-574.
  4. Abetz L, Rajagopalan K, Mertzanis P, Begley C, Barnes R, Chalmers R, et al. Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients. Health Qual Life Outcomes. 2011 Dec 8;9:111.
  5. Miller KL, Walt JG, Mink DR, Satram-Hoang S, Wilson SE, Perry HD, et al. Minimal clinically important difference for the ocular surface disease index. Arch Ophthalmol. 2010 Jan;128(1):94-101.
  6. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000 May;118(5):615-21.
  7. Begley CG, Caffery B, Chalmers RL, GL M, Dry Eye Investigation Study Group. Use of the dry eye questionnaire to measure symptoms of ocular irritation in patients with aqueous tear deficient dry eye. Cornea. 2002 Oct;21(7):664–70.
  8. Sakane Y, Yamaguchi M, Yokoi N, Uchino M, Dogru M, Oishi T, et al. Development and validation of the Dry Eye-Related Quality-of-Life Score questionnaire. JAMA Ophthalmol. 2013 Oct;131(10):1331-8.
  9. McMonnies CW, Ho A. Responses to a dry eye questionnaire from a normal population. J Am Optom Assoc. 1987 Jul;58(7):588-91.
  10. Johnson ME, Murphy PJ. Measurement of ocular surface irritation on a linear interval scale with the ocular comfort index. Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4451-8.
  11. Schaumberg DA, Gulati A, Mathers WD, Clinch T, Lemp MA, Nelson JD, et al. Development and validation of a short global dry eye symptom index. Ocul Surf. 2007 Jan;5(1):50-7.
  12. Blackie CA, Solomon JD, Scaffidi RC, Greiner JV, Lemp MA, Korb DR. The relationship between dry eye symptoms and lipid layer thickness. Cornea. 2009 Aug;28(7):789–94.
  13. Chalmers RL, Begley CG, Caffery B. Validation of the 5-Item Dry Eye Questionnaire (DEQ-5): Discrimination across self-assessed severity and aqueous tear deficient dry eye diagnoses. Cont Lens Anterior Eye. 2010 Apr;33(2):55-60.
  14. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000 May;118(5):615-21.
  15. Beltran F, Ramos Betancourt N, Martinez J, Santacruz Valdes C, Babayan A, Ramírez-Assad C, et al. Transcultural validation of ocular surface disease index (OSDI) questionnaire for Mexican population. Invest Ophthalmol Vis Sci. 2013;54(15):6050.
  16. Babayan A, Ramos Betancourt A, Beltran F, Martinez J, Santacruz Valdes C, Ramírez-Assad C, et al. Transcultural validation of McMonnies questionnaire for Mexican population. Invest Ophthalmol Vis Sci. 2013;54(15):6049.
  17. Martinez JD, Galor A, Amescua G, Ramos-Betancourt N, Beltran F, Babayan Sosa A, et al. Transcultural validation of the 5-item Dry Eye Questionnaire for the Mexican population. Int Ophthalmol. 2019 Oct;39(10):2313-2324.
  18. Jacobi C, Jacobi A, Friedrich EK, Cursiefen C. Tear film osmolarity measurements in dry eye disease using electrical impedance technology. Cornea. 2011 Dec;30(12):1289–92.
  19. Lemp MA, Bron AJ, Baudouin C, Benitez Del Castillo JM, Geffen D, Tauber J, et al. Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol. 2011 May;151(5):792-8 e1.
  20. Sullivan BD, Whitmer D, Nichols KK, Tomlinson A, Foulks GN, Geerling G, et al. An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6125-30.
  21. Sullivan B. Challenges in using signs and symptoms to evaluate new biomarkers of dry eye disease. Ocul Surf. 2014 Jan;12(1):2-9.
  22. Keech A, Senchyna M, Jones L. Impact of time between collection and collection method on human tear fluid osmolarity. Curr Eye Res. 2013 Apr;38(4):428-436.
  23. Mathews PM, Karakus S, Agrawal D, Hindman HB, Ramulu PY, Akpek EK. Tear osmolarity and correlation with ocular surface parameters in patients with dry eye. Cornea. 2017 Nov;36(11):1352-1357.
  24. Sullivan BD, Crews LA, Sönmez B, de la Paz MF, Comert E, Charoenrook V, et al. Clinical utility of objective tests for dry eye disease- variability over time and implications for clinical trials and disease management. Cornea. 2012 Sep;31(9):1000–8.
  25. Mooi JK, Wang MTM, Lim J, Muller A, Craig JP. Minimising instilled volume reduces the impact of fluorescein on clinical measurements of tear film stability. Cont Lens Anterior Eye. 2017 Jun;40(3):170-4.
  26. Gumus K, Crockett CH, Rao K, Yeu E, Weikert MP, Shirayama M, et al. Noninvasive assessment of tear stability with the tear stability analysis system in tear dysfunction patients. Invest Ophthalmol Vis Sci. 2011 Jan 21;52(1):456-61.
  27. Abdelfattah NS, Dastiridou A, Sadda SR, Lee OL. Noninvasive imaging of tear film dynamics in eyes with ocular surface disease. Cornea. 2015 Oct;34 Suppl 10:S48–52.
  28. Tsubota K, Yokoi N, Watanabe H, Dogru M, Kojima T, Yamada M, et al. A new perspective on dry eye classification: proposal by the Asia Dry Eye Society. Eye & Contact Lens. 2020 Jan;46:s2-s13.
  29. Jiang Y, Ye H, Xu J, Lu Y. Noninvasive Keratograph assessment of tear film break-up time and location in patients with age-related cataracts and dry eye syndrome. J Int Med Res. 2014 Apr;42(2):494–502.
  30. Kim J, Kim JY, Seo KY, Kim T im, Chin HS, Jung JW. Location and pattern of non-invasive keratographic tear film break-up according to dry eye disease subtypes. Acta Ophthalmol. 2019 Dec;97(8):e1089–97
  31. Bron AJ, Argueso P, Irkec M, Bright FV. Clinical staining of the ocular surface: mechanisms and interpretations. Prog Retin Eye Res. 2015 Jan;44:36-61.
  32. Begley C, Caffery B, Chalmers R, Situ P, Simpson T, Nelson JD. Review and analysis of grading scales for ocular surface staining. Ocul Surf. 2019 Apr;17(2):208-20.
  33. Golding TR, Bruce AS, Mainstone JC. Relationship between tear-meniscus parameters and tear-film breakup. Cornea. 1997 Nov;16(6):649-61.
  34. Arriola-Villalobos P, Fernandez-Vigo JI, Diaz-Valle D, Peraza-Nieves JE, Fernandez-Perez C, Benitez-Del-Castillo JM. Assessment of lower tear meniscus measurements obtained with Keratograph and agreement with Fourier-domain optical-coherence tomography. Br J Ophthalmol. 2015 Aug;99(8):1120-5.
  35. Doguizi S, Sekeroglu MA, Inanc M, Yılmazbas P. Evaluation of tear meniscus dimensions using anterior segment optical coherence tomography in video terminal display workers. Clin Exp Optom. 2019 Sep;102(5):478-484.
  36. Singh A, Vanathi M, Kishore A, Gupta N, Tandon R. Evaluation of strip meniscometry, tear meniscus height and depth in the diagnosis of dry eye disease in asian Indian eyes. Ocul Surf. 2019 Oct;17(4):747-752.
  37. Shinzawa M, Dogru M, Miyasaka K, Shimazaki J, Sekiryu T. Application of CASIA SS-1000 Optical Coherence Tomography Tear Meniscus Imaging in Testing the Efficacy of New Strip Meniscometry in Dry Eye Diagnosis. Eye Contact Lens. 2018 Sep;44 Suppl 1:S44-S49.
  38. Lee KB, Koh KM, Kwon YA, Song SW, Kim BY, Chung JL. Changes in Tear Volume after 3% Diquafosol Treatment in Patients with Dry Eye Syndrome: An Anterior Segment Spectral-domain Optical Coherence Tomography Study. Korean J Ophthalmol. 2017 Aug;31(4):306-312.
  39. Wang Y, Xu Z, Gong Q, Ren W, Chen L, Lu F, Hu L. The Role of Different Tear Volume Detection Methods in the Evaluation and Diagnosis of Mild Dry Eye Disease. Transl Vis Sci Technol. 2022 Mar 2;11(3):15.
  40. Singh S, Rajput A, Mohamed A, Mittal V. Spectral domain optical coherence tomography for measuring tear film meniscus height and its relationship with epiphora. Indian J Ophthalmol. 2018 Nov;66(11):1592-1594.
  41. Rocha-de-Lossada C, Sánchez-González JM, Zamorano-Martín F, Rachwani-Anil R, Torras-Sanvicens J, Peraza-Nieves J. Influence of Sodium Hyaluronate Concentration in Tear Meniscus Height: 10-min Dynamic Profile After Single Instillation. Eye Contact Lens. 2021 Jun 1;47(6):330-334.
  42. Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK. The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Invest Ophthalmol Vis Sci. 2011 Mar;52(4):1994-2005.
  43. Tomlinson A, Bron AJ, Korb DR, Amano S, Paugh JR, Pearce EI, et al. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci. 2011 Mar 30;52(4):2006-49.
  44. Markoulli M, Duong TB, Lin M, Papas E. Imaging the tear film: a comparison between the subjective Keeler Tearscope-Plus and the objective Oculus(R) Keratograph 5M and LipiView(R) interferometer. Curr Eye Res. 2018 Feb;43(2):155-62.
  45. Guillon JP. Abnormal lipid layers. Observation, differential diagnosis, and classification. Adv Exp Med Biol. 1998;438:309-13.
  46. Koh S, Maeda N, Hirohara Y, Mihashi T, Bessho K, Hori Y, et al. Serial measurements of higher-order aberrations after blinking in patients with dry eye. Invest Ophthalmol Vis Sci. 2008 Jan;49(1):133-138.
  47. Montés-Micó R, Cáliz A, Alió JL. Wavefront analysis of higher order aberrations in dry eye patients. J Refract Surg. 2004 May-Jun;20(3):243-247.
  48. Gao Y, Liu R, Liu Y, Ma B, Yang T, Hu C, et al. Optical quality in patients with dry eye before and after treatment. Clin Exp Optom. 2021 Jan;104(1):101-106.
  49. Binotti WW, Bayraktutar B, Ozmen MC, Cox SM, Hamrah P. A Review of imaging biomarkers of the ocular surface. Eye Contact Lens. 2020 Mar;46 Suppl 2(Suppl 2):S84-S105.
  50. Schulze MM, Ng A, Yang M, Panjwani F, Srinivasan S, Jones LW, et al. Bulbar redness and dry eye disease: comparison of a validated subjective grading scale and an objective automated method. Optom Vis Sci. 2021 Feb 1;98(2):113-120.
  51. Messmer EM, von Lindenfels V, Garbe A, Kampik A. Matrix metalloproteinase 9 testing in dry eye disease using a commercially available point-of-care immunoassay. Ophthalmology. 2016 Nov;123(11):2300-2308.
  52. Roda M, Corazza I, Bacchi Reggiani ML, Pellegrini M, Taroni L, Giannacare G, et al. Dry eye disease and tear cytokine levels-a meta-analysis. Int J Mol Sci. 2020 Apr 28;21(9):3111.
  53. Versura P, Giannaccare G, Vukatana G, Mulè R, Malavolta N, Campos EC. Predictive role of tear protein expression in the early diagnosis of Sjögren's syndrome. Ann Clin Biochem. 2018 Sep;55(5):561-570.
  54. Song Y, Yu S, He X, Yang L, Wu Y, Qin G, et al. Tear film interferometry assessment after intense pulsed light in dry eye disease: a randomized, single masked, sham-controlled study. Cont Lens Anterior Eye. 2021 Aug 22;101499.
  55. Lee JH, Kim CH, Choe CM, Choi TH. Correlation analysis between ocular surface parameters with subjective symptom severity in dry eye disease. Korean J Ophthalmol. 2020 Jun;34(3):203-209.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.